Source: Annual Congress 2004 - Primary care: asthma treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hirata, Y. Touda, H. Fujiwara, K. Komuta (Osaka, Osakasayama, Habikino, Japan). Clinical review of long-term pranlukast therapy in adult patients with bronchial asthma. Eur Respir J 2004; 24: Suppl. 48, 1982

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of the long-term therapy with simbicort in children with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005 Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Efficacy of symbicort administration in patients with bronchial asthma Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Efficacy of the using budesonide/formoterol in patients with bronchial asthma (BA): the study of routine clinical practice Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Study of the Glutoxim-containing inhalation treatment in bronchial asthma patients Source: Eur Respir J 2002; 20: Suppl. 38, 373s Year: 2002 Clinical efficacy of new non-freon aerosol troventol in asthma patients Source: Annual Congress 2006 - Recent advances in asthma treatment Year: 2006 Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Pharmacoepidemiological analysis of the treatment of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Real-life long-term omalizumab therapy in children with severe allergic asthma Source: Eur Respir J 2015; 46: 856-859 Year: 2015 Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005 Clinical and histological impact of omalizumab in oral corticosteroid-dependent severe allergic asthma Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002 Safety of omalizumab therapy in children with allergic asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017 Perception of the of inhaled corticosteroids role in treatment of bronchial asthma in Saudi adult patients Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004 Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma Source: Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019 Year: 2020 Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012